Glycolysis Inhibition Targets HNF-1β-Positive Clear Cell Carcinoma
ESMO Open describes a metabolic approach that combines glycolysis inhibition and mitochondrial biogenesis to trigger ROS-dependent cell death in clear cell carcinoma.
This section contains the website’s posts.